Charged Particle and Conventional Radiotherapy: Current Implications as Partner for Immunotherapy

por Marcus, Damiënne, Lieverse, Relinde I. Y., Klein, Carmen, Abdollahi, Amir, Lambin, Philippe, Dubois, Ludwig J., Yaromina, Ala
Publicado 2021

Human fibronectin extra domain B as a biomarker for targeted therapy in cancer

por Lieverse, Relinde I. Y., Marcus, Damiënne, van der Wiel, Alexander M. A., Van Limbergen, Evert J., Theys, Jan, Yaromina, Ala, Lambin, Philippe, Dubois, Ludwig J.
Publicado 2020

Hypoxia PET Imaging with [18F]-HX4—A Promising Next-Generation Tracer

por Sanduleanu, Sebastian, van der Wiel, Alexander M.A., Lieverse, Relinde I.Y., Marcus, Damiënne, Ibrahim, Abdalla, Primakov, Sergey, Wu, Guangyao, Theys, Jan, Yaromina, Ala, Dubois, Ludwig J., Lambin, Philippe
Publicado 2020

Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised contr...

por Lieverse, Relinde I. Y., Van Limbergen, Evert J., Oberije, Cary J. G., Troost, Esther G. C., Hadrup, Sine R., Dingemans, Anne-Marie C., Hendriks, Lizza E. L., Eckert, Franziska, Hiley, Crispin, Dooms, Christophe, Lievens, Yolande, de Jong, Monique C., Bussink, Johan, Geets, Xavier, Valentini, Vincenzo, Elia, Giuliano, Neri, Dario, Billiet, Charlotte, Abdollahi, Amir, Pasquier, David, Boisselier, Pierre, Yaromina, Ala, De Ruysscher, Dirk, Dubois, Ludwig J., Lambin, Philippe
Publicado 2020